- Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook CNBC
- Pfizer Beats Sales Estimates on Demand for Older Drugs Bloomberg.com
- Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand The Wall Street Journal
- Pfizer Stock Falls After Solid Earnings. What’s Troubling Wall Street. Barron’s
- Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4 CY2025 Yahoo Finance
Credit: Source link


























